- Home
- IMUX vs SNT Comparison
IMUX vs SNT Comparison
Compare IMUX & SNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- SNT
- Stock Information
- Founded
- IMUX 2016
- SNT 1965
- Country
- IMUX United States
- SNT Canada
- Employees
- IMUX N/A
- SNT N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- SNT Telecommunications Equipment
- Sector
- IMUX Health Care
- SNT Telecommunications
- Exchange
- IMUX Nasdaq
- SNT Nasdaq
- Market Cap
- IMUX 90.4M
- SNT 95.2M
- IPO Year
- IMUX N/A
- SNT 1993
- Fundamental
- Price
- IMUX $0.82
- SNT $4.39
- Analyst Decision
- IMUX Strong Buy
- SNT
- Analyst Count
- IMUX 5
- SNT 0
- Target Price
- IMUX $7.50
- SNT N/A
- AVG Volume (30 Days)
- IMUX 1.4M
- SNT 57.0K
- Earning Date
- IMUX 11-06-2025
- SNT 11-11-2025
- Dividend Yield
- IMUX N/A
- SNT N/A
- EPS Growth
- IMUX N/A
- SNT N/A
- EPS
- IMUX N/A
- SNT 0.22
- Revenue
- IMUX N/A
- SNT $38,038,000.00
- Revenue This Year
- IMUX N/A
- SNT N/A
- Revenue Next Year
- IMUX N/A
- SNT N/A
- P/E Ratio
- IMUX N/A
- SNT $20.18
- Revenue Growth
- IMUX N/A
- SNT 12.79
- 52 Week Low
- IMUX $0.56
- SNT $1.40
- 52 Week High
- IMUX $2.11
- SNT $5.04
- Technical
- Relative Strength Index (RSI)
- IMUX 45.68
- SNT 51.47
- Support Level
- IMUX $0.75
- SNT N/A
- Resistance Level
- IMUX $0.90
- SNT $4.74
- Average True Range (ATR)
- IMUX 0.05
- SNT 0.19
- MACD
- IMUX -0.00
- SNT -0.16
- Stochastic Oscillator
- IMUX 47.20
- SNT 92.62
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.